Cargando…
Lasofoxifene: Evidence of its therapeutic value in osteoporosis
INTRODUCTION: Osteoporosis is a skeletal disorder characterized by compromised bone strength and increased risk of fracture. It is a common disorder in elderly subjects and represents a major public health problem, affecting up to 40% postmenopausal women and 15% of men. Among the several therapeuti...
Autores principales: | Gennari, Luigi, Merlotti, Daniela, De Paola, Vincenzo, Nuti, Ranuccio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899785/ https://www.ncbi.nlm.nih.gov/pubmed/20694069 |
Ejemplares similares
-
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Gennari, Luigi, et al.
Publicado: (2010) -
Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008) -
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009) -
Current options for the treatment of Paget’s disease of the bone
por: Merlotti, Daniela, et al.
Publicado: (2009) -
Aromatase Activity and Bone Loss in Men
por: Merlotti, Daniela, et al.
Publicado: (2011)